Jersey Intel Exclusive

NJEDA cuts drugmaker’s rent $1.2M as state lab campus sits 37% empty

October 23, 2026 · Jersey Intel Staff

Jersey Intel infographic: NJEDA cut Ascendia Pharmaceuticals' rent by $1.2 million for 12 months at the New Jersey Bioscience Center, which is 37% vacant; official portrait of NJEDA CEO Evan Weiss. — Photo: Evan Weiss, NJEDA CEO | State of New Jersey, Office of the Governor (official portrait) / Wikimedia Commons (Public domain).

JERSEY INTEL EXCLUSIVE

First reported by Jersey Intel. The New Jersey Economic Development Authority on Thursday, Oct. 22, cut a drugmaker’s rent at its state-owned lab campus in North Brunswick, N.J., by $1.2 million for a year, saying it wants to keep the tenant as the campus sits 37% empty. The reasons the company gave for needing relief were kept in a confidential exhibit, according to the authority’s own recording of the meeting.

The board approved the lease change for Ascendia Pharmaceuticals at the New Jersey Bioscience Center by voice vote, with no opposition, recusals or abstentions announced. It also approved $77.5 million in Aspire tax credits for three affordable-housing projects in Newark, N.J.

Image: Jersey Intel infographic. Photo: NJEDA CEO Evan Weiss, State of New Jersey, Office of the Governor (official portrait) / Wikimedia Commons (public domain).

What we know: Ascendia’s rent of $1.9 million a year drops to $700,000 for 12 months. The $1.2 million difference is to be repaid over seven years, staff told the board.
Why it matters: Staff said the campus is 37% vacant and would reach 56% if Ascendia left. The tenant’s reasons and the claims it is giving up were not made public.
What’s next: The agenda item gives the authority’s CEO, Evan Weiss, power to sign the amendment. The lease document and Exhibit C have not been posted.

What the board approved for Ascendia

A manager in the authority’s real estate department laid out the terms, according to the recording the authority posted after the meeting (the item starts at about 1:03:50):

Ascendia’s current lease payment is $1.9 million a year.
For 12 months, rent is reduced by $1.2 million, to an annual payment of $700,000, “to be repaid over seven years.”
The whole lease term is extended by three months.
Rent is permanently reduced on 5,000 square feet of unfinished space, priced at the fair-market rent of equivalent manufacturing or warehouse space.

The public agenda also lists two items that were not discussed aloud: a “tenant’s release of claims” and delegated authority for the chief executive officer to sign the amendment. The agenda does not say what claims Ascendia had against the authority.

“The reasons given for the rent reduction request are in the confidential Exhibit C, which has been provided for you,” the staff member told board members. Staff said it had reviewed the company’s financials and five-year strategic plan and found them “acceptable.”

A 37% empty state lab campus

Staff gave a second reason for the deal: the Bioscience Center “currently has a 37% vacancy,” which it called significant but recent, after “a long-term tenant” left 70,000 square feet in June. “An additional vacancy would take us to 56%,” the staff member said. The authority’s real estate committee reviewed the request on Sept. 22.

Ascendia, a contract drug developer and manufacturer, occupies 59,558 square feet in a full building at 661 Route 1 North after an earlier lease expansion, Real Estate NJ reported.

Board members’ only questions were about timing: whether the change was for one year or three months. Staff said the full lease is extended three months and the rent change lasts one year, with a seven-year repayment term.

$77.5 million in Aspire credits for Newark housing

The board also approved three Aspire tax-credit awards, each at 60% of eligible project costs, according to the staff presentations (starting about 0:47:00 in the recording):

Cottage Place Apartments LLC, 125 West Kinney St.: $29,676,042 to redevelop 100 affordable rental units in 20 buildings, at or below 60% of area median income. Total cost $54,388,070. The co-applicant is an entity wholly owned by the Urban League of Essex County.
Crown Village Building 1 LLC, 572-588 South Orange Ave.: $27,807,019 for 105 units for residents 55 and older, plus 10,000 square feet of retail, on the former Pabst Blue Ribbon brewery site. Total cost $52,440,241.
Crown Village Building 4 LLC, 554-566 South Orange Ave.: $20,040,299 for 69 family rental units on the same site. Total cost $38,284,912.

Staff said the Crown Village developer “does not have any experience with the NJEDA” and that these would be its first Aspire-funded projects. The nonprofit partner on both Crown Village buildings is the Passaic Affordable Housing Coalition, of Passaic, N.J. Part of the former brewery site is in Irvington, N.J., and staff said Thursday’s awards cover only the Newark portion. A board member asked about the brownfield cleanup; staff said it had already occurred and is not part of the project costs. Staff said Building 1 construction is expected to start in January 2027 and take about 18 months.

Questions the record doesn’t answer

What claims did Ascendia release, and what were they worth?
What is in confidential Exhibit C, and will the authority release a redacted version?
What interest or security, if any, applies to the $1.2 million to be repaid over seven years?
Which long-term tenant left 70,000 square feet in June, and what is the authority doing to fill the campus?

Our Oct. 22 roundup listed these items as “on the agenda” without dollar amounts, because the authority had not posted its board book. As of Friday morning, the board book and an approvals release were still not posted; the recording is the only public record of the amounts.

Have the lease amendment, Exhibit C or the Bioscience Center’s vacancy figures? Send documents to jerseyintel@gmail.com.